SSH Sunshine Heart INC

CHF Solutions, Inc. To Announce Second Quarter 2020 Financial Results on August 4, 2020

CHF Solutions, Inc. To Announce Second Quarter 2020 Financial Results on August 4, 2020

EDEN PRAIRIE, Minn., July 28, 2020 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its second quarter 2020 financial results will be released on Tuesday, August 4, 2020. The company will host a conference call and webcast at 9:00 AM ET that morning, during which management will discuss the company's financial results and provide a general business overview.

To access the live webcast, please visit the Investors page of the CHF Solutions website at or access the webcast directly at .  Alternatively, you may access the live conference call by dialing (877) 303-9826 (U.S.) or (224) 357-2194 (international) and using conference ID: 3591247.  An audio archive of the webcast will be available following the call on the Investor page at .

About CHF Solutions

CHF Solutions, Inc. (Nasdaq: CHFS) is a medical device company dedicated to improving the lives of patients suffering from fluid overload through science, collaboration, and innovation. The company is focused on developing, manufacturing and commercializing the Aquadex SmartFlow™ system for ultrafiltration therapy. CHF Solutions is headquartered in Minneapolis, Minn., with wholly-owned subsidiaries in Australia and Ireland. The company has been listed on the Nasdaq Capital Market since February 2012.

CONTACTS:

INVESTORS:

Claudia Napal Drayton
Chief Financial Officer
CHF Solutions, Inc.
952-345-4205
 

- MEDIA:

Jessica Stewing
Health+Commerce
260-336-6202
EN
28/07/2020

Underlying

SSHSunshine Heart INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Sunshine Heart INC

 PRESS RELEASE
Free
SSH Sunshine Heart ...

American Medical Association Issues New CPT Code for Nuwellis’ Aquadex...

American Medical Association Issues New CPT Code for Nuwellis’ Aquadex Ultrafiltration The newly classified code expands access to life-saving, novel fluid removal technology EDEN PRAIRIE, Minn., July 13, 2021 (GLOBE NEWSWIRE) -- In an effort to increase the availability of life-saving ultrafiltration therapy to people experiencing fluid overload, the American Medical Association (AMA) has issued a new Category III Current Procedural Terminology (CPT®) code, 0692T for Therapeutic Ultrafiltration. The new CPT code will come into effect on January 1, 2022, at which time providers can util...

July 13, 2021 1 EN
 PRESS RELEASE
Free
SSH Sunshine Heart ...

Nuwellis Inc. to Participate at the 2021 Ladenburg Thalmann Healthcare...

Nuwellis Inc. to Participate at the 2021 Ladenburg Thalmann Healthcare Conference EDEN PRAIRIE, Minn., July 06, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), a company focused on providing solutions for patients suffering from fluid overload, today announced that, Nestor Jaramillo, Chief Executive officer, and George Montague, Chief Financial Officer, are scheduled to participate in the 2021 Ladenburg Thalmann Healthcare Conference on Wednesday, July 14th, 2021. Event:2021 Ladenburg Thalmann Healthcare Conference  Format:Presentation & Fireside Chat  Date:Wednesday, July 14, 202...

July 6, 2021 1 EN
 PRESS RELEASE
Free
SSH Sunshine Heart ...

Nuwellis, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 563...

Nuwellis, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) EDEN PRAIRIE, Minn., July 01, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), today announced that, effective June 30, 2021, the Compensation Committee of the Board of Directors approved an equity award to George Montague under Nuwellis’ 2021 Inducement Plan, as a material inducement to Mr. Montague entering into employment with the company as its Chief Financial Officer and Treasurer. The equity award was approved in accordance with NASDAQ Listing Rule 5635(c)(4), which also requires a public announceme...

July 1, 2021 1 EN
 PRESS RELEASE
Free
SSH Sunshine Heart ...

Nuwellis, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 563...

Nuwellis, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) EDEN PRAIRIE, Minn., June 24, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), today announced that, effective June 22, 2021, the independent directors approved four equity awards under Nuwellis’ 2021 Inducement Plan, as material inducement to four individuals entering into employment with the company. The equity awards were approved in accordance with NASDAQ Listing Rule 5635(c)(4), which also requires a public announcement of equity awards that are not made under a stockholder approved equity plan. I...

June 24, 2021 1 EN
 PRESS RELEASE
Free
SSH Sunshine Heart ...

Nuwellis Announces New Appointments to Leadership Team

Nuwellis Announces New Appointments to Leadership Team George Montague to serve as Chief Financial Officer and Neil P. Ayotte, to serve as General Counsel and Chief Compliance Officer EDEN PRAIRIE, Minn., June 22, 2021 (GLOBE NEWSWIRE) -- Continuing its dynamic growth in support of its commitment to expanding access to life-saving ultrafiltration therapies for adult and pediatric patients suffering from fluid overload, Nuwellis, Inc. (Nasdaq: NUWE), formerly CHF Solutions, Inc., today announced the appointment of George Montague as Chief Financial Officer, effective June 28, 2021. Neil ...

June 22, 2021 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch